Methotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015PsoriasisPsoriatic Arthritis
Secukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015PsoriasisPsoriatic Arthritis
Brodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeksMarch 21, 2015PsoriasisPsoriatic Arthritis
Halting biologics before surgery tied to flares in psoriasis, psoriatic arthritisMarch 13, 2015Psoriatic ArthritisPsoriasis
Interleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvementsMarch 9, 2015PsoriasisPsoriatic Arthritis
Data suggest link between tonsillectomy, psoriasis improvementFebruary 25, 2015PsoriasisPsoriatic Arthritis
Ixekizumab improves lesions in patients with chronic plaque psoriasis after 20 weeksFebruary 24, 2015Psoriatic ArthritisPsoriasis
